Gilead (GILD) Veklury Data Positive in Hospitalized COVID PatientsZacks Investment Research • 06/22/21
Gilead says real-world data shows COVID-19 drug Veklury can reduce the risk of deathMarket Watch • 06/21/21
Gilead's Veklury® (Remdesivir) Associated With a Reduction in Mortality Rate in Hospitalized Patients With COVID-19 Across Three Analyses of Large Retrospective Real-World Data SetsBusiness Wire • 06/21/21
Gilead to Present More Than 70 Abstracts From Diverse Liver Disease Programs At The International Liver Congress™ 2021Business Wire • 06/21/21
Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 06/17/21
Gilead's Kite Pharma Collaborates With Shoreline Biosciences For Cell Therapies For Cancer SettingsBenzinga • 06/17/21
Kite and Shoreline Biosciences Enter Into Strategic Partnership to Develop Novel Allogeneic Cell TherapiesBusiness Wire • 06/17/21
Longer-term Data for Kite's Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative AnalysisBusiness Wire • 06/12/21
U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis CBusiness Wire • 06/10/21
Gilead Sciences, Inc. (GILD) Management Presents at Goldman Sachs 42nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/10/21
Gilead Sciences: Rebuilding Under No Real Pressure - Buy For Near-Term Profits, UpsideSeeking Alpha • 06/06/21
Gilead's Trodelvy New Subgroup Data Shows Benefit in Second-Line Breast Cancer PatientsBenzinga • 06/04/21
Kite's Tecartus® Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia Earning Priority Review DesignationBusiness Wire • 06/04/21
Trodelvy® Demonstrates Superior Outcomes to Standard of Care in Second-Line Treatment of Metastatic Triple-Negative Breast Cancer in Phase 3 ASCENT StudyBusiness Wire • 06/04/21
Gilead Sciences, Inc. (GILD) Management Presents at Annual Bernstein Strategic Decisions Conference (Transcript)Seeking Alpha • 06/03/21